Skip to content

A Randomized, Multicentre, Seamless, Adaptive Phase I/II Study to Determine Safety and Efficacy of RhinoPHAGE-2A cocktail in Patients with Chronic Rhinosinusitis Associated with Staphylococcus aureus Infection

Status
Withdrawn
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-516220-34-00
Acronym
Rhinophage-One
Enrollment
600
Registered
2025-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Rhinosinusitis associated with Staphylococcus aureus Infection

Interventions

None listed

Sponsors

Instytut Immunologii I Terapii Doswiadczalnej Im Ludwika Hirszfelda Pan We Wroclawiu
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Poland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026